Objectives. To update the medical literature on recent cellular and molecular advances in otitis media disease models with a principal focus on developments in the past 5 years. We also aim to explain recent translational advances in cellular and molecular biology that have influenced our understanding and management of otitis media.
I nfections in the middle ear trigger a series of cellular responses in middle ear epithelium. The subsequent pathogenesis of otitis media (OM) from acute to chronic, however, is complex and multifactorial. Mechanisms of propensity to OM have been shown to involve, among many other factors, mutations or polymorphisms in genes that mediate innate immunity and cellular signaling pathways that promote healing and recovery after inflammation. According to recent reports, the following cellular signaling pathways are altered following OM infection: Toll-like receptor (TLR) cascade, the inflammasome, NF-kB signaling, and the TGF-b pathway. During disease progression, mucous cell metaplasia or hyperplasia is frequently observed in animal models and human tissue specimens. In turn, the occurrence of mucous cell metaplasia or hyperplasia promotes the chronicity of OM as well as relapses of acute infections due to the abundant production of mucin glycoproteins. This State of the Art Review updates recent advances in innate immune and cell signaling responses, genetic predispositions that affect molecular pathways, mucin responses, oxidative stress, and novel molecular diagnostics.
Methods
A comprehensive review of the medical literature was conducted by the Panel 8 members of the Post-Conference Research Symposium of the 18th International Symposium on Recent Advances in Otitis Media. PubMed was used as the search engine. Given instructions provided by the symposium organizers, each panel member conducted an independent search engine query on the basis of his or her area of expertise. Collectively, the following search terms were employed with the term otitis media: molecular biology, cell biology, innate immunity, oxidative stress, mucins, and molecular diagnostics. Additional search terms included trans-tympanic drug delivery, photonics, and OCT. Included articles for this State of the Art Review were limited to those published in the English language from January 1, 2010, to July 31, 2015.
Discussion

Innate Immune Responses and Molecular Signaling in the Middle Ear
The pathogenesis of acute and chronic OM (COM) is complex and multifactorial. However, mechanisms of proneness to OM have been shown to involve, among other factors, genes that mediate innate immunity and signaling pathways that promote healing and recovery after inflammation. 1 According to recent research reports, the following cellular signaling pathways are altered following OM infection: TLR cascade, inflammasome, NF-kB signaling, and TGF-b pathway. In humans, polymorphisms in genes encoding the TLRs 2,3 have been shown to be associated with OM susceptibility, as have genes for the innate immune cellular signaling effectors TNF-a, IL-1b, IL-6, IL-8, and IL-10. 4, 5 In addition, recent reports showed distorted mRNA and protein levels of TLR2, TLR4, TLR5, and TLR9 plus the downstream signaling molecules TNF-a, IL-1b, IFN-g, IL-6, and IL-8 in mucosal and effusion patient samples. [6] [7] [8] [9] [10] [11] In animal studies, deficiency or absence of genes that encode for receptors (TLR2, TLR4, TLR9) 12 or downstream targets TNF (tumor necrosis factor), 13 JNK1, and JNK2 14 leads to abnormal OM recovery. In particular, mouse model studies have shown that in the absence of TLR2 or MyD88, initial neutrophil and macrophage recruitments are significantly delayed and are deficient in phagocytic function, which leads to prolonged inflammatory response and results in persistence of viable bacteria in the middle ear for long periods (up to 42 days, as compared with 5 days in wild-type mice). In addition, TLR2-deficient mice undergoing OM due to Streptococcus pneumonia showed decreased expression of NOD2, IL1, NF-kB, TNF-a, MIP1a, Muc5ac, and Muc5b and delayed bacterial clearance. As stated before, lack of TLR2 or MyD88 resulted in reduced TNF induction in the middle ear, suggesting that TNF is a major effector of TLR signaling during experimental, nontypeable Haemophilus influenzae-induced OM. However, application of recombinant TNF to TNF-deficient macrophages does not result in restoration of normal levels of phagocytosis and killing by these cells. Interestingly, recombinant CCL3 (a member of the CC chemokine family known to be an important chemotactic and regulatory agent for macrophages) restores MyD88-, TLR2-, and TNF-deficient macrophage function to normal and reduces the deficit in OM recovery observed in TNF-null mice. 13 This identifies CCL3 as another key TLR effector molecule in the middle ear, operating downstream from TNF. Nonetheless, neither TLRs nor their signaling molecules appear to be singularly essential for the initial expression of nontypeable H influenzae-mediated inflammation in the middle ear, implicating multiple innate immune receptors and signaling networks alternative to TLRs in the middle ear, such as NOD-like receptors (NLRs) as well as bacterial DNA receptors, plus others. 15, 16 Expression of members of the NLR family of inflammasome receptors was significantly upregulated early in OM 9 and cholesteatoma, 17 potentially activating specific downstream regulatory cascades that contribute to the proliferative inflammatory response observed during OM. Activation of the pyrin domain containing NLRs (NLRPs) results in the formation of inflammasome, a large multimolecular signaling platform consisting of an active NLRP, the bipartite adaptor protein ASC, and caspase 1. Mice deficient in ASC, which modulates caspase 1 recruitment and activation, were more susceptible to middle ear infection than wild-type mice. 18 This heightened susceptibility was associated with decreased activation of IL-1b, implicating the inflammasome and the NLRPs to play a role in OM resolution.
The results of these recent studies imply that innate immune responses are involved in inflammatory middle ear disease. One may speculate on the regulatory mechanisms that alter the expression of TLRs and NLRPs during these circumstances. Studies on experimental models indicate intricate pathways where different microbes seem to influence the innate immune response. 19, 20 Susceptibility to OM might depend on inborn errors of innate immune defense as well as the impact of the infection itself.
Mutagenesis studies have identified that the Junbo and Jeff mutant mouse models exhibit the COM phenotype. 21 The Junbo mutation maps to the zinc finger domain at the Evi1 gene, while the Jeff mutation maps to the Fbxo11 gene. Both the EVI1 and FBXO11 proteins have been shown to interact with the transforming growth factor TGFb pathway by functional assays. Evi1 is involved in repressing TGF-b signaling by interacting with the MH2 domain of Smad3. Polymorphisms at the FBXO11 and several genes related to the TGF-b pathway (eg, Smad 2, Smad 4, and ZNF8) have been associated with increased susceptibility to OM in human genome-wide association studies and linkage studies. 22, 23 In mouse models, Tgif-knockout mice (a negative regulator to TGF-b) exhibited COM at 3 weeks of age, accompanied by conductive hearing loss and raised levels of inflammatory gene expression of TNF-a and IL-1b in ear fluids. 24 Finally, the NF-kB/IkB pathway is involved in regulating many immunologic functions. 25 At the cellular level, NF-kB is present as a complex with its inhibitor IkB. However, activation of the kinase IKK complex-which is composed of active IKKa, IKKb, and scaffold protein NEMO (NF-kB essential modulator)-leads to phosphorylation and degradation of the IkB protein and to release of the NF-kB subunit. The active NF-kB subunits p65 and p50 translocate into the nucleus, where they can induce the expression of specific genes that have DNA-binding sites for NF-kB in their promoters. During middle ear infection, activation of the NF-kB signaling pathway occurs in the early phase 16 and leads to the increase in the gene expression levels of IFN-b/TNF-a/IL-8 and mucin MUC5AC, among other inflammatory-related genes. 26 
Biofilms and Neutrophil Extracellular Traps
Bacteria persist within biofilms on the middle ear mucosa of children with recurrent and chronic OM; however, the mechanisms by which these develop remain to be elucidated. Biopsies can be difficult to obtain from children, and their small size limits analysis. One study investigated biofilm presence in middle ear effusion (MEE) from children with recurrent acute OM (rAOM) to determine if these may represent infectious reservoirs similar to those on the mucosa. This was examined through culture, viability staining, and fluorescent in situ hybridization to determine the bacterial species present. Most MEEs had live bacteria present according to viability staining (32 of 36), and all effusions had bacteria present per the universal fluorescent in situ hybridization probe (26 of 26). Of these, 70% contained 2 otopathogenic species. Extensive DNA stranding was also present. This DNA was largely host derived, representing neutrophil extracellular traps (NETs) within which live bacteria in biofilm formations were present. When treated with the recombinant human deoxyribonuclease-1, or Dornase alfa, these strands were observed to completely fragment. 27 ã´Bacterial biofilms composed of multiple live otopathogenic species can be demonstrated in the MEEs of children with rAOM, which contain extensive DNA stranding from NETs. The NETs contribute to the viscosity of the effusion, potentially contributing to its failure to clear as well as to biofilm development. In this regard, agents such as Dornase alfa that can fragment these strands may play a role in future OM treatment.
Oxidative Stress in Middle Ear Inflammatory Response
Oxidative stress is defined as tissue damage resulting from an imbalance between the production of free radicals and the ability of the body to prevent their harmful effects through neutralization by antioxidants. The role of oxidative stress in the pathogenesis of OM is not well understood. Baysal et al measured the oxidative stress index, serum total oxidant status, and serum total antioxidant status in 75 patients: 25 cholesteatomatous COM patients, 25 noncholesteatomas COM patients, and 25 healthy control subjects. 28 They found a significant imbalance in oxidative stress and antioxidant enzyme levels in COM patients with cholesteatoma. Balikci et al measured oxidative protein product levels in middle ear fluid and plasma obtained from 25 children with COM with effusion (COME) and 30 healthy control children. 29 While plasma oxidative protein product levels did not differ between COME and control children, MEE fluid oxidative protein levels were significantly higher than plasma oxidative protein levels in the COME group. The role of protein oxidation imbalance in the pathogenesis of COME warrants further investigation. Such studies could reveal novel treatment modalities for this disease.
Genetic Predispositions for Severe Middle Ear Inflammatory Responses
Classical studies in twins reveal a substantial heritable component to rAOM and OME. [30] [31] [32] More recently, a group in Western Australia evaluated an association between polymorphisms in the human homologues EVI1 and FBXO11 and susceptibility to rAOM or COME in a cohort of families treated by the authors (the Western Australian Family Study of OM) and in a unique cohort of children followed longitudinally since birth for 20 years (the Western Australian Pregnancy Cohort Study, or ''Raine Study''). 33 DNA samples were collected from 561 affected children and their parents, representing 434 families. Affected children had .3 physician-diagnosed episodes of acute OM (AOM) or ventilation tube insertion for rAOM/COME. Directed analysis of genome-wide single-nucleotide polymorphism chip data from 1198 individuals participating in the Raine Study was also undertaken (253 children with severe OM based on medical record review and 866 controls). A significant association was found between singlenucleotide polymorphisms at FBXO11 and severe OM or rAOM in both cohorts (P \ .009) but no consistent association for any of the EVI1 variants. Multivariate analyses showed that the association at FBXO11 was independent of associated environmental risk factors for OM (ie, day care attendance, allergy). These data confirm a genetic basis for susceptibility to severe OM and suggest that this might be mediated by variants at FBXO11 that result in inflammatory dysfunction by altering regulation of the TGFb pathway. Further studies are needed to assess possible variations in geographic distribution of FBXO11 variants to investigate the mechanism by which they increase the risk of severe OM and to consider the implications for identification and treatment of children with a genetic propensity to develop severe middle ear disease.
In a further study, a genome-wide association study examining the OM phenotype was undertaken. Data for 2,524,817 single-nucleotide polymorphisms (535,544 quality-controlled single-nucleotide polymorphisms genotyped by Illumina 660W-Quad; 1,989,273 by imputation) were analyzed for association with OM in 416 cases and 1075 controls from the Western Australian Pregnancy Cohort Study (Raine Study). This identified CAPN14 and GALNT14 on chromosome 2p23.1 and the BPIFA gene cluster on chromosome 20q11.21 as novel candidate genes which warrant further analysis. 34 
Mucins in Middle Ear Disease
Mucins are macroglycoconjugates that are heavily glycosylated proteins, which are a family of glycoproteins with up to 20 members. A mucin glycoprotein typically consists of 10% to 15% protein backbones and 85% to 90% sugar side chains. Mucins, with mucin chaperones such as trefoil factors, are tightly packed into mucous granules that are positive for alcian blue/periodic acid-Schiff stain. The exact role of different mucin subtypes in the promotion of OM progression is only recently beginning to be elucidated. In the airways, the most typically secreted mucins are MUC5AC and MUC5B.
A recent study published in Nature showed that Muc5bnull mice demonstrated a high amount of morbidity in the airways due to severe infection, resulting in systemic infection and ultimately death. 35 An overproduction of Muc5ac was demonstrated by histology techniques in these mice. The ears were severely inflamed and highly infected by different bacteria in all of the Muc5b-knockout mice. Importantly, Muc5ac knockout mice did not show any difference as compared with the wild-type mice in terms of middle ear infection susceptibility or inflammation. Thus, Muc5b glycoprotein is needed in the airways and the middle ear to protect mice against bacterial invasion, and further research is needed to analyze the regulation of Muc5b during OM.
It is known that bacterial products regulate MUC5AC expression in the middle ear, yet the regulation of MUC5B is comparatively underinvestigated. Most studies used bacteria or bacterial lysates in the human middle ear epithelial cell line HMEEC-1 and the murine middle ear epithelial cell line mMEEC. HMEEC-1 exposed to S pneumonia, nontypeable H influenzae, and Moraxella catarrhalis whole lysates showed an induction of the mRNA of the mucins MUC2, MUC5AC, and MUC5B, 36 while S pneumonia live bacteria were able to induce MUC5AC mRNA. 37 The commensal organism Staphylococcus epidermidis found in the ear of COM patients was also shown to induce MUC5AC and MUC5B mRNA in mMEEC as well as Cxcl2 proinflammatory cytokine. 38 The mechanisms under MUC5AC gene expression induction in response to live S pneumonia were shown to implicate phosphodiesterase 4B, which inhibits a negative regulator of MUC5AC: the MAP kinase phosphatase 1. 37 The transcription factor NF-kB, widely implicated in inflammatory processes, was also demonstrated to be activated in response to S epidermidis lysates in mMEEC. 38 The importance of inflammatory factors in the mucoid metaplasia observed during OM was confirmed by the study of Nakamura et al, 39 as the cell line mMEEC differentiated in mucus-like cells in response to the combination of TNF-a, the epithelial differentiation factor retinoic acid, and the transcription factor Math1. The periodic acid-Schiff test showed an increase of glycoprotein content in the treated cells as well as an increase in mRNA of the mucin chaperone trefoil factors TFF1, TFF2, and TFF3. This differentiation was under the control of EGFR, MAPK, NF-kB, and TGF-b pathways, as the use of inhibitors or these signaling pathways prevented mMEEC to produce mucin granules in response to TNF-a, retinoic acid, and Math1. This underlines the role of inflammatory mediators in OM and the complex regulation of mucoid metaplasia.
Role of Pollutants in Middle Ear Inflammation
Recently, efforts were made to understand the implication of pollutants in the development of OM, exposing the cell line HMEEC-1 or rats to either 1 of 2 atmospheric pollutants: urban particulate matter (UPM; ie, diesel exhaust particles) or acrolein (contained in cigarette smoke). The transtympanic injection of UPM into the middle ear of rats showed a progressive thickening of the middle ear epithelium until 14 days after exposure, the infiltration of inflammatory cells in the mucosa, and the upregulation of MUC5B mRNA at all time points, whereas MUC5AC mRNA was induced only at day 1 after exposure. 40 Epithelial sodium channels were also regulated by UPM, with ENaC-a, ENaC-b, and ENaC-g mRNA being downregulated at day 1 and only ENaC-b and ENaC-g upregulated at day 14. The inflammatory and mucoid effect of UPM was confirmed with HMEEC-1, as the particle exposure induced the inflammatory inductor cyclooxygenase COX-2 as well as MUC5AC mRNA. 41 The exposure of HMEEC-1 to diesel exhaust particles showed similar effects, as it induced COX-2 and MUC5AC mRNA and the proinflammatory cytokine TNF-a-effects also demonstrated in response to the cigarette smoke component acrolein. 42, 43 Thus, pollutants can induce OM characteristics, probably because of their inflammatory effects.
Innovative Molecular Techniques for Imaging and Diagnosis of OM
Despite the widespread prevalence of OM, the accurate diagnosis of this condition and other middle ear lesions, such as cholesteatoma, remains challenging in the clinical setting. Current ear examination methods suffer from significant observer variability and provide minimal understanding of a disease's underlying biochemistry and structural changes.
Standard ear evaluations are still performed primarily through visual inspection with a white light otoscope that has remained virtually unchanged for more than a century. Photonic applications for middle ear disease have been described over the last 2 decades, but this has not translated to daily implementation in clinical practice. This may be associated with the elevated costs of biomedical devices and the reluctance of physicians to utilize ''nonconventional'' imaging methods and lasers in an office setting, especially when it comes to diagnostic applications rather than treatment.
In the last 5 years, there has been a renewed interest in diagnostic photonic applications for OM. The most common described optical modality has been optical coherence tomography (OCT). OCT uses reflections of near-infrared light (~800-1300). The use of light rather than sound waves allows for imaging resolution up to 100 times higher than that of ultrasound, resulting in images that closely resemble histology. OCT performs depth-resolved optical imaging into tissue and detects only the returning photons that remain coherent, limiting photons that would contribute to noise. Most important, these images can be captured noninvasively without the need for stains or dyes.
Custom-built OCT otoscopy systems with handheld probes have been described to aid in the diagnosis of OM. [44] [45] [46] This technique has been used to image the tympanic membrane and malleus under a variety of conditions and, most recently, biofilm adhered to the tympanic membrane. The tympanic membrane is approximately 100 nm in thickness, while a biofilm varies in range from tens to hundreds of micrometers. 47 This level of detail is possible due to the depth of penetration of 2 to 3 mm and a high degree of resolution of several micrometers. However, OCT has significant limitations, including that it requires a sophisticated optical setup, which makes it difficult to make it portable and cost-effective. At the same time, it provides very different views of the tympanic membrane compared with what physicians are accustomed to.
Similar portable photonic applications for middle ear examination include multiwavelength fluorescence and reflectance otoscopes, 48, 49 which offer high molecular specificity and the ability to perform real-time video rate measurements in a noninvasive label-free manner. These optical tools potentially offer an understanding of the tissue structure and chemistry, collectively yielding objective recognition of pathology that is currently unattainable with standard otoscopy. For example, the definition of the middle ear pathology in chemical terms may have major implications because biochemical modifications in between states can help detect early signs of worsening or resolution of OM that may not be readily visible with white light otoscopy.
Most recently, Raman spectroscopy has been utilized to differentiate between congenital cholesteatoma and myringosclerosis by analyzing the spectral patterns of differentially expressed molecules. 50 Differentiation of these is particularly challenging for primary care practitioners using standard otoscopy, due to their similarity in visual appearance. Raman spectroscopy yielded a positive predictive value of 99.02%, a negative predictive value of 95.63%, a sensitivity of 95.48%, a specificity of 99.06%, and an overall accuracy of 97.27% 50 in distinguishing between cholesteatoma and myringosclerosis based solely on their chemical composition.
Innovative Techniques for Middle Ear Drug Delivery
Delivering drugs and other therapeutic agents in the middle ear is still an open challenge, especially when considering novel approaches for molecular targeting within the middle ear. Currently, there are no effective treatments for COME, nor are there medical treatments that block the progression of AOM to COME. Tympanostomy tube placement under general anesthesia for treatment of recurrent AOM or COME is the most common pediatric surgical procedure requiring anesthesia in the United States and many other countries. AOM is still the diagnosis that causes most prescriptions of antibiotics to small children, although guidelines for treatment of AOM advocate watchful waiting strategies for uncomplicated cases. Clearly, there is a critical public health need for alternative strategies to treat AOM and COME, not only to minimize side effects and the development of resistant microorganisms, but also to reduce the costly burden of surgical procedures in children and the consequences of general anesthesia.
Passive diffusion across the tympanic membrane is the subject of active research. While the early attempts at using electrophoresis across the eardrum have not been the subject of much recent research, more recent and promising developments in therapeutic delivery have occurred with the use of drug-eluting nanoparticles with a magnetic core. At very small scales (10-20 nm), iron oxide nanobeads will follow magnetic field gradients, from low to high. Thus, nanoparticles-loaded with molecules (steroids, antibiotics, COX-2 inhibitors, growth factors) or with nucleic acids (siRNA, shRNA, ODN) and with a core made of iron oxide nanobeads-can be pushed 51 across the eardrum and to possibly coat the middle ear walls atraumatically. Depending on the nanoparticle coating and method of preparation, the therapeutic agents will then elute from the nanoparticles over periods from a few minutes to several days. After some time, the particles are then eliminated through the eustachian tube.
The possibility of delivering therapeutic or imaging agents through the eardrum presents challenges. The molecules have to be strongly bound to the nanoparticles so that they are not ''stripped off'' during transport through the eardrum, but once inside the eardrum, they have to be released in the desired time window. Magnetic gradients have to be established such that the particle-containing fluid does not damage the eardrum or cause discomfort but so the force is strong enough to transport the particles through the eardrum and possibly across the middle ear space. Preliminary experiments indicate that this is fairly easy to do in small mammals, although experiments in the human eardrum have not yet been performed, to our knowledge.
Implications for Practice
The molecular understanding of OM disease progression has rapidly advanced over the last 5 years. The roles of inflammation, mucins, and cell signaling mechanisms have been elucidated and defined. To summarize, it appears that the OM represents a condition of either mutated or excessive innate immune epithelial responses mediated primarily through pattern recognition receptors such as TLRs and NLRs. Advances in the field provide a plethora of opportunities for innovative molecular targeting in the development of novel therapeutic strategies for OM. Exciting opportunities exist for research in novel means of local drug delivery into the middle ear and in using technology to optimize the diagnosis of OM.
Synthesis of Recent Advances
It is pretty clear that the pathophysiology of the OM continuum from acute to COM is complex and multifactorial. However, mechanisms of OM progression have been comprehensively demonstrated through both in vitro and in vivo models to involve, among other factors, genes and pathways that mediate innate immunity and promote healing and recovery after inflammation. Of particular note, the TLR cascade signaling to the inflammasome, via NF-kB signaling and the TGF-b pathway, appears to be of particular relevance in middle ear epithelial progression of disease. Notably, these proinflammatory responses appear to converge on a prosecretory epithelial effect driven by an overproduction and hypersecretion of mucin genes and glycoproteinsthe most important, MUC5B. In turn, MUC5B is critical for an innate immune defense against pathogens in the middle ear.
Indeed, given the cumulative data represented by the body of work cited herein over the past 5 years, we hypothesize a model for OM progression whereby acute bacterial infection leads to middle ear epithelial secretion of mediators, driven by TLR signaling and the inflammasome, which set up a primarily neutrophilic inflammatory response predominantly mediated by the chemotaxic effect of IL-8 as a predominant epithelial cytokine. Recruited neutrophils can effect bacterial kill through phagocytosis and NETosis, the latter ostensibly being triggered by the cytokine itself or the bacterial effect on the neutrophil. At this point, the resulting infected fluid will either clear or persist. Persistent or recurrent inflammation results in epithelial mucin glycoprotein overproduction and secretion, predominantly MUC5B, which in turn associates with accumulated NETs. NET mediators themselves, such as neutrophil elastase, may promote and sustain epithelial mucin hypersecretion. Middle ear NETs ultimately get involved with bacterial biofilms as host components of the biofilm milieu. which further potentiates nonclearance of MEE, due to the exceedingly high viscosity of mucin and extracellular DNA combination in the fluid.
Gaps for Future Research
Despite rapid advances in the molecular understanding in OM disease progression, there has been little-to-no progress made in innovative means of treating this condition. After more than 50 years, AOM is still the diagnosis that causes the most prescriptions of antibiotics to small children, and surgery for COME remains the most common procedure done under anesthesia in the United States. Clearly, there is a critical public health need for alternative strategies to treat AOM and COME. We feel that future areas of research in OM should include the following:
Investigation of novel areas of molecular therapeutics targeting the modulation of inflammatory responses in middle ear epithelium-TLR, NFkB, and TGFb-2 mediators are attractive molecular targets in this regard. Development of novel strategies to modulate but not completely abrogate MUC5B and NETosis innate immune responses as means to medically assist middle ear fluid clearance in children where active infection has appeared to resolve. Expansion of novel methodologies for middle ear drug delivery, either through gene therapy or transtympanic drug delivery.
